EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,533,000 | +8.6% | 27,260 | +4.7% | 0.53% | +1.1% |
Q4 2020 | $2,333,000 | -13.2% | 26,035 | +0.1% | 0.52% | -21.0% |
Q3 2020 | $2,687,000 | +29.3% | 26,008 | -1.0% | 0.66% | +23.2% |
Q2 2020 | $2,078,000 | +37.3% | 26,277 | +0.5% | 0.54% | +20.4% |
Q1 2020 | $1,513,000 | +5.4% | 26,143 | -1.8% | 0.45% | +26.3% |
Q4 2019 | $1,436,000 | +3.4% | 26,620 | +0.2% | 0.35% | -0.3% |
Q3 2019 | $1,389,000 | +7.7% | 26,572 | -0.5% | 0.36% | +9.2% |
Q2 2019 | $1,290,000 | -4.8% | 26,702 | -0.4% | 0.32% | -6.9% |
Q1 2019 | $1,355,000 | +8.7% | 26,812 | +27.5% | 0.35% | +0.9% |
Q4 2018 | $1,246,000 | +0.1% | 21,023 | +11.2% | 0.35% | +9.8% |
Q3 2018 | $1,245,000 | +30.4% | 18,905 | 0.0% | 0.32% | +25.5% |
Q2 2018 | $955,000 | -1.8% | 18,905 | +2.3% | 0.25% | -4.2% |
Q1 2018 | $973,000 | +9.7% | 18,480 | -3.1% | 0.26% | +7.4% |
Q4 2017 | $887,000 | +15.9% | 19,080 | +1.0% | 0.24% | +12.4% |
Q3 2017 | $765,000 | +19.3% | 18,900 | 0.0% | 0.22% | +21.9% |
Q2 2017 | $641,000 | – | 18,900 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |